HSCSNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCSW

HeartSciences Inc.

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026

$3.07+0.05 (+1.66%)

Close on Oct 19, 2026

Market cap: $11.26M
P/E (TTM): –
Dividend yield: 0.00%

HeartSciences Inc. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2026 2026-04-30	FY 2025 2025-04-30	FY 2024 2024-04-30	FY 2023 2023-04-30	FY 2022 2022-04-30
Revenue	0.00	0.00	0.02	0.01	0.01
Cost of Revenue	0.00	0.00	0.01	0.00	0.01
Gross Profit	0.00	0.00	0.01	0.00	0.01
Research & Development	2.84	4.39	2.88	2.46	3.00
Selling, General & Admin	5.58	3.97	3.44	3.65	1.71
Operating Expenses	8.42	8.36	6.32	6.12	4.72
Operating Income	-8.41	-8.35	-6.31	-6.11	-4.71
Interest Expense	0.75	0.50	0.35	0.24	0.37
Other Non-Operating Income	-0.73	-0.41	-0.30	-0.24	-0.12
Income Tax Expense	0	0	–	–	–
Net Income	-9.14	-8.77	-6.61	-6.35	-4.83
EPS (Basic)(per share)	-3.48	-9.34	-18.74	-80.00	-145.00
EPS (Diluted)(per share)	–	-9.34	-18.74	-80.00	-145.00
Shares Outstanding (Basic, Weighted)(shares)	2.63	0.94	0.35	0.08	0.03
Shares Outstanding (Diluted, Weighted)(shares)	2.63	0.94	0.35	0.08	0.03
Dividend per Share(per share)	0.00	0.00	–	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jul 31, 2026

Profitability, TTM

Gross margin: 60.9%
Operating margin: -209733.1%
Net margin: -227024.2%
Return on equity, FY2026: -4239.9%

Financial strength

Current ratio: 0.14
Debt to equity: 0.00
Debt to assets: 0.0%
Cash to current liabilities: 0.5%

Valuation

P/E ratio: –
Price to sales: 2492.51
Price to book: –
Dividend yield: 0.00%